Screening for Social Determinants of Health in Patients With Systemic Lupus Erythematosus: A Point‐of‐Care Feasibility Study
Arthritis Care & Research · 2025
DOI: 10.1002/acr.25572 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Arthritis Care & Research, 2025. Verfasst von S Sam Lim und 11 weiteren Autor:innen. Beteiligte Einrichtung: Emory University School of Medicine and Grady Health System, Atlanta, Georgia. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Social Determinants of Health, Point-of-Care Systems, Mass Screening. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAMS NIH HHS, GSK.
Abstract (Originalsprache)
Objective
Social determinants of health (SDoH) can impact outcomes but are not routinely screened for in US outpatient rheumatology clinics. This study determined the feasibility of routine point‐of‐care SDoH screening among patients with systemic lupus erythematosus (SLE) and associated barriers and facilitators at the physician, care team, and patient levels.
Methods
This observational, prospective, mixed‐methods pilot study (GSK Study 219011) conducted in two large academic tertiary lupus clinics in the United States screened adults with SLE for SDoH over two weeks (institution 1, July to August 2023) and seven weeks (institution 2, August to October 2023). Patient demographics and patient‐reported responses to questions covering up to eight SDoH domains chosen by participating institutions were collected, and an optional patient experience survey was conducted afterward. Participating physicians and care teams were asked questions on screening implementation, tool usability and comprehension, clinician acceptance, and facilitators of use. Transcripts were analyzed using thematic analysis.
Results
The study included 69 patients with SLE across both institutions; 65 completed the patient experience survey. SDoH screening was successfully implemented with minimal disruption to clinical workflow and was viewed as valuable by physicians, care teams, and patients. Reported facilitators to successful SDoH screening included institutional leadership buy‐in to address health equity and a brief screening tool format (five minutes or less). Barriers included limited resources and insufficient time or training.
Conclusion
With an appropriately resourced and trained care team, successful routine SDoH screening in lupus clinics is feasible, valuable to clinicians and care teams, and effective for connecting patients to needed social resources. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Emory University School of Medicine and Grady Health System, Atlanta, Georgia.
- GSK, Philadelphia, Pennsylvania.
- Atlas Clarity LLC, San Francisco, California.
- Washington University School of Medicine, St Louis, Missouri.
- GSK, Durham, North Carolina GSK, Durham, North Carolina, USA.
- Emory University School of Medicine, Atlanta, Georgia.
ORCID-Profile: S Sam Lim, Vijay R Nadipelli, Daphne Lew, Jeff Berko, Alfred H J Kim
Förderung
- NIAMS NIH HHS
- GSK
Zitieren
APA
Lim, S. S., Nadipelli, V. R., Bruno, M., Lew, D., Rubin, B., Dunlop-Thomas, C. M., Hulcher, K., Mitchell, K. R., Demetriou, L., Berko, J., Bao, J., & Kim, A. H. J. (2025). Screening for Social Determinants of Health in Patients With Systemic Lupus Erythematosus: A Point‐of‐Care Feasibility Study. Arthritis Care & Research. https://doi.org/10.1002/acr.25572
Vancouver
Lim SS, Nadipelli VR, Bruno M, Lew D, Rubin B, Dunlop-Thomas CM, et al. Screening for Social Determinants of Health in Patients With Systemic Lupus Erythematosus: A Point‐of‐Care Feasibility Study. Arthritis Care & Research. 2025. doi:10.1002/acr.25572
BibTeX
@article{Lim2025,
author = {Lim, S Sam and Nadipelli, Vijay R and Bruno, Michelle and Lew, Daphne and Rubin, Bernard and Dunlop-Thomas, Charmayne M and Hulcher, Kelsey and Mitchell, Kristi R and Demetriou, Lydia and Berko, Jeff and Bao, Jason and Kim, Alfred H J},
title = {Screening for Social Determinants of Health in Patients With Systemic Lupus Erythematosus: A Point‐of‐Care Feasibility Study},
journal = {Arthritis Care & Research},
year = {2025},
doi = {10.1002/acr.25572}
}
EUVIMED